EDGe Surgical’s recent $1.3 million funding round marks a significant step in scaling the commercial deployment of its flagship Ortho EDG® device—an advanced, single-use digital depth gauge for orthopedic and spine surgeries. This strategic capital infusion will be used to expand the company’s sales force, increase inventory, enhance customer service, and restructure existing debt, thereby streamlining the company’s path to broader market penetration. The investment comes at a time when the healthcare sector is actively seeking technology that not only improves surgical outcomes but also reduces costs and infection risks, aligning well with EDGe’s value proposition.

The Ortho EDG® device replaces traditional manual depth gauges with a sterile, disposable digital instrument that delivers real-time intraoperative measurements. This innovation enhances procedural accuracy, reduces implant waste, shortens OR times, and lowers the likelihood of surgical site infections—an increasingly important factor in hospital purchasing decisions. The launch of two new SKUs, the 100mm for deeper anatomical access and the 35mm for smaller surgical spaces, reflects EDGe’s focus on addressing a broader range of orthopedic procedures. This expanded offering boosts the device’s versatility across orthopedic subspecialties, from trauma to minimally invasive surgeries.

The results of early market adoption have been promising, underscoring the healthcare system's appetite for digital, disposable tools that increase procedural efficiency and safety. CEO Leo Carayannopoulos highlighted that this funding will enable EDGe to meet rising demand, reinforce its market presence, and sustain momentum with new product variants. Overall, the successful funding round and product expansion position EDGe Surgical for accelerated growth in a competitive medtech landscape, while supporting its long-term vision of becoming a leader in digital orthopedic instrumentation.